MORGESE, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 2.370
EU - Europa 967
AS - Asia 838
SA - Sud America 134
AF - Africa 78
Continente sconosciuto - Info sul continente non disponibili 72
OC - Oceania 1
Totale 4.460
Nazione #
US - Stati Uniti d'America 2.312
SG - Singapore 261
IT - Italia 200
VN - Vietnam 176
CN - Cina 169
RU - Federazione Russa 157
BR - Brasile 106
DE - Germania 103
UA - Ucraina 96
SE - Svezia 83
FI - Finlandia 76
IE - Irlanda 70
TR - Turchia 57
HK - Hong Kong 53
CI - Costa d'Avorio 52
FR - Francia 50
GB - Regno Unito 41
DK - Danimarca 31
CA - Canada 30
IN - India 30
BD - Bangladesh 26
KR - Corea 19
PL - Polonia 14
AR - Argentina 12
MX - Messico 12
NL - Olanda 11
JP - Giappone 10
LT - Lituania 10
MA - Marocco 10
ES - Italia 8
IQ - Iraq 8
ZA - Sudafrica 8
BE - Belgio 5
MY - Malesia 4
PE - Perù 4
PH - Filippine 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
AZ - Azerbaigian 3
CO - Colombia 3
GP - Guadalupe 3
HN - Honduras 3
ID - Indonesia 3
PK - Pakistan 3
PT - Portogallo 3
SV - El Salvador 3
BG - Bulgaria 2
CL - Cile 2
EC - Ecuador 2
KE - Kenya 2
PR - Porto Rico 2
PY - Paraguay 2
SA - Arabia Saudita 2
SC - Seychelles 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AU - Australia 1
BB - Barbados 1
BY - Bielorussia 1
CM - Camerun 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
EG - Egitto 1
GT - Guatemala 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
PS - Palestinian Territory 1
SN - Senegal 1
TL - Timor Orientale 1
TN - Tunisia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.389
Città #
Ashburn 417
Chandler 186
Singapore 181
San Jose 125
Jacksonville 115
Fairfield 99
New York 87
Council Bluffs 77
Boardman 73
Dublin 70
Des Moines 66
Wilmington 60
Ho Chi Minh City 56
Los Angeles 56
Seattle 56
Hong Kong 53
Abidjan 52
Beijing 48
Dallas 48
Woodbridge 48
Hanoi 45
Houston 44
Munich 41
Cambridge 33
Ann Arbor 32
Princeton 31
Helsinki 30
The Dalles 30
Turku 29
Lauterbourg 26
Moscow 26
Turin 26
Lawrence 25
San Mateo 24
Ancona 22
Milan 22
Centro 21
Orem 21
Phoenix 19
Santa Clara 15
Warsaw 14
Washington 14
Chicago 13
Hefei 13
Montreal 13
Da Nang 12
São Paulo 12
Chennai 11
Frankfurt am Main 11
Guangzhou 11
Rome 11
San Diego 10
Brooklyn 9
Buffalo 9
Pune 9
Atlanta 8
Columbus 8
Denver 8
Haiphong 8
Poplar 8
Tokyo 8
Irving 7
London 7
Norwalk 7
Vilnius 6
Amsterdam 5
Falls Church 5
Johannesburg 5
Manchester 5
Mexico City 5
Urbisaglia 5
Ankara 4
Brussels 4
City of London 4
Guarulhos 4
Hải Dương 4
Jiaxing 4
Miano 4
North Bergen 4
Nuremberg 4
Shanghai 4
Wuxi 4
Ấp Tháp Mười 4
Baku 3
Boston 3
Brasília 3
Bến Tre 3
Charlotte 3
Cleveland 3
Kilburn 3
Montegiorgio 3
Mumbai 3
Paris 3
San Salvador 3
Secaucus 3
Vienna 3
Anápolis 2
Arequipa 2
Baghdad 2
Baytown 2
Totale 2.907
Nome #
Electrolyte disorders in advanced non-small cell lung cancer patients treated with immune check-point inhibitors: a systematic review and meta-analysis 266
Prognostic relevance of programmed cell death protein 1/programmed death-ligand 1 pathway in thymic malignancies with combined immunohistochemical and biomolecular approach 223
Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy 208
Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy 175
Thymic neoplasms: an update on the use of chemotherapy and new targeted therapies. A literature review. 173
Pre-treatment systemic immune-inflammation represents a prognostic factor in patients with advanced non-small cell lung cancer 173
Electrolyte disorders in cancer patients: a systematic review 171
Gender Differences and Outcomes in Melanoma Patients 170
Clinical and pathologic predictors of clinical outcome of malignant pleural mesothelioma 160
High CTLA-4 expression correlates with poor prognosis in thymoma patients 160
Hyponatremia is a predictor of hospital length and cost of stay and outcome in cancer patients. 159
Systemic treatment for lung carcinoids: from bench to bedside 155
Gastrointestinal neuroendocrine tumors: Searching the optimal treatment strategy-A literature review 154
Impact of phosphoinositide-3-kinase and vitamin D3 nuclear receptor single-nucleotide polymorphisms on the outcome of malignant melanoma patients 154
Hormonal receptors in lung adenocarcinoma: expression and difference in outcome by sex 153
Gender differences and outcome of melanoma patients 152
Hyponatraemia is a predictor of clinical outcome for malignant pleural mesothelioma 152
Lynch syndrome-associated lung cancer: pitfalls of an immunotherapy-based treatment strategy in an unusual tumor type 150
Hyponatremia in cancer patients: Time for a new approach 150
IMPACT OF VEGF, VEGFR, PDGFR, HIF AND ERCC1 GENE POLYMORPHISMS ON THYMIC MALIGNANCIES OUTCOME 146
Locally advanced rectal cancer: the importance of a multidisciplinary approach. 144
Prognostic Impact of Blood Lipid Profile in Patients With Advanced Solid Tumors Treated With Immune Checkpoint Inhibitors: A Multicenter Cohort Study 143
Medical treatment for gastro-entero-pancreatic neuroendocrine tumours 143
Risk of hyponatraemia in cancer patients treated with targeted therapies: A systematic review and meta-analysis of clinical trials 140
New findings on thymic epithelial tumors: Something is changing 128
Prognostic models to predict survival in patients with advanced non-small cell lung cancer treated with first-line chemo- or targeted therapy 123
Treatment of advanced small cell lung cancer 122
Comparison Between First Line Target Therapy and Immunotherapy in Different Prognostic Categories of BRAF Mutant Metastatic Melanoma Patients: An Italian Melanoma Intergroup Study 113
Totale 4.460
Categoria #
all - tutte 19.762
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.762


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022131 0 0 0 0 4 22 7 9 19 23 16 31
2022/2023556 30 70 33 50 24 116 0 25 113 4 80 11
2023/2024344 43 7 23 21 44 113 4 22 3 16 3 45
2024/2025560 85 42 11 3 39 24 47 22 98 31 79 79
2025/20261.607 151 83 55 197 178 120 304 151 117 144 34 73
2026/2027396 63 122 52 138 21 0 0 0 0 0 0 0
Totale 4.460